Institutional Ownership
Apimeds Pharmaceuticals Us I
CUSIP 03771D102COM SHSAPUSQ1 2026
13D / 13G Filings
3
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
37.9%
Max % of class reported
Institutional Holders
4
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
3 filings · latest Feb 11, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Hemenway Trust Co LLC | 274.0K | $490.3K |
| 2 | Geode Capital Management, LLC | 40.1K | $71.7K |
| 3 | Two Sigma Securities, LLC | 10.6K | $18.9K |
| 4 | Ubs Group AG | 4.2K | $7.5K |